Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Equity (2019 - 2025)

Revolution Medicines has reported Return on Equity over the past 7 years, most recently at 0.7% for Q4 2025.

  • Quarterly results put Return on Equity at 0.7% for Q4 2025, down 70.0% from a year ago — trailing twelve months through Dec 2025 was 0.7% (down 70.0% YoY), and the annual figure for FY2025 was 0.58%, down 58.0%.
  • Return on Equity for Q4 2025 was 0.7% at Revolution Medicines, down from 0.21% in the prior quarter.
  • Over the last five years, Return on Equity for RVMD hit a ceiling of 0.0% in Q4 2024 and a floor of 0.7% in Q4 2025.
  • Median Return on Equity over the past 5 years was 0.31% (2023), compared with a mean of 0.29%.
  • Biggest five-year swings in Return on Equity: soared 33bps in 2024 and later tumbled -70bps in 2025.
  • Revolution Medicines' Return on Equity stood at 0.3% in 2021, then fell by -21bps to 0.36% in 2022, then rose by 9bps to 0.33% in 2023, then skyrocketed by 100bps to 0.0% in 2024, then tumbled by -3836259bps to 0.7% in 2025.
  • The last three reported values for Return on Equity were 0.7% (Q4 2025), 0.21% (Q3 2025), and 0.11% (Q2 2025) per Business Quant data.